[Morning session on the fourth day of the 2026 State Talks: Kelun Pharmaceutical, Tasly, etc. enter negotiations] September 8th, at about 8 o'clock today, the morning session on the fourth day of the 2026 National Basic Medical Insurance Drug List Negotiation Bidding and Commercial Insurance Innovative Drug List Price Negotiation officially opened. Reporters observed at the scene that Kelun Pharmaceutical, Luye Pharmaceutical, Chia Tai Tianqing, Shenwei Pharmaceutical, Jiangxi Pharmaceutical Capital Zhangshu, Weikang Pharmaceutical, Tasly, Jilin Aodong, etc. were about 20 Representatives from several companies lined up to enter the venue. This is also the first time since the first day of the state-to-state talks that a large number of traditional Chinese medicine companies and Western medicine companies have begun negotiations to enter the country at the same time. (Reporters Lu Afeng and Yu Miao)